Switchable car t cell strategy against osteosarcoma

HIGHLIGHTS

• who: Laura Hidalgo from the Cellular Biotechnology Unit, Instituto de Investigaciu00f3n de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain have published the research work: Switchable CAR T cell strategy against osteosarcoma, in the Journal: (JOURNAL)
• what: The authors report a switchable cell strategy based on anti-FITC cells and a switch molecule conjugated with FITC for targeting (OS) tumors. The authors evaluate the capacity of an monoclonal antibody conjugated with FITC (anti-B7-H3-FITC mAb) to control the antitumor activity of anti-FITC cells. The authors demonstrate that anti-B7-H3 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.